A study of diclofenac-induced teratogenicity during organogenesis using a whole rat embryo culture model.
Open Access
- 1 November 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 16 (11) , 2390-2393
- https://doi.org/10.1093/humrep/16.11.2390
Abstract
Diclofenac is a non-steroidal anti-inflammatory drug, commonly used by reproductive age women for the treatment of a variety of conditions. However, there is limited information regarding the teratogenic effects of this drug.Keywords
This publication has 16 references indexed in Scilit:
- Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control studyBMJ, 2001
- Clinical Pharmacokinetics of DiclofenacClinical Pharmacokinetics, 1997
- Prostaglandin Synthetase Inhibitors in PregnancyObstetrical & Gynecological Survey, 1993
- Diclofenac SodiumDrugs, 1988
- The Honeybee Syndrome — Implications of the Teratogenicity of Mannose in Rat-Embryo CultureNew England Journal of Medicine, 1984
- Aspirin-induced teratogenesis: A unique pattern of cell death and subsequent polydactyly in the ratJournal of Experimental Zoology, 1981
- Radiation teratogenesisTeratology, 1980
- WHOLE‐EMBRYO CULTURE AND THE STUDY OF MAMMALIAN EMBRYOS DURING ORGANOGENESISBiological Reviews, 1978
- Studies on metabolism and identification of the causative agent in aspirin teratogenesis in ratsTeratology, 1971
- Multiple Comparisons Using Rank SumsTechnometrics, 1964